For SCLC, patients with limited disease are treated with radiation, and extensive disease is treated with chemotherapy plus radiation, with survival rates of 10% and 3%, respectively.
Refinements in treatment have increased the 5-year survival to close to 70 percent, but treatment still involves invasive surgery, radiation therapy and chemotherapy.